Compound Detail
CHEMBL1980297
ILORASERTIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL1980297 |
| Name | ILORASERTIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | WPHKIQPVPYJNAX-UHFFFAOYSA-N |
102
Targets
147
Activities
2
Assay Types
11
PK Parameters
20
Publications
6
Known Names
2
Indications
4
Mechanisms
Molecular Properties
488.6
MW (Da)
5.18
ALogP
7
HBA
4
HBD
118.1
PSA (Ų)
0.26
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serine/threonine-protein kinase Aurora inhibitor | INHIBITOR | Serine/threonine-protein kinase Aurora | ✓ | ✓ |
| Vascular endothelial growth factor receptor inhibitor | INHIBITOR | Vascular endothelial growth factor receptor | ✓ | ✓ |
| SRC inhibitor | INHIBITOR | SRC | ✓ | ✓ |
| Platelet-derived growth factor receptor inhibitor | INHIBITOR | Platelet-derived growth factor receptor | ✓ | ✓ |
Indications
Neoplasms Neoplasms
Activity Summary
Ki 102 meas. best 9.3
IC50 45 meas. best 8.95
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 18600.0 | ng.hr.mL-1 | Mus musculus |
| CL | 5.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 5.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 5.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 5.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| F | 47.0 | % | Mus musculus |
| T1/2 | 4.7 | hr | Mus musculus |
| T1/2 | 4.0 | hr | Rattus norvegicus |
| T1/2 | 4.0 | hr | Mus musculus |
| T1/2 | 4.0 | hr | Canis lupus familiaris |
| Vd | 1.7 | L.kg-1 | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Mus musculus | 10 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Canis familiaris | 6 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Rattus norvegicus | 4 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Aurora kinase B | 3 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Cytochrome P450 3A4 | 3 |
| 22695126 | 10.1016/j.bmcl.2012.05.067 | Vascular endothelial growth factor receptor 2 | 2 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Vascular endothelial growth factor receptor 2 | 2 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | No relevant target | 2 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Aurora kinase A | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Vascular endothelial growth factor receptor 1 | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Platelet-derived growth factor receptor beta | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Macrophage colony-stimulating factor 1 receptor | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Tyrosine-protein kinase Lck | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Tyrosine-protein kinase ABL1 | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Proto-oncogene tyrosine-protein kinase receptor Ret | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Tyrosine-protein kinase Fyn | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Fibroblast growth factor receptor 1 | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | ALK tyrosine kinase receptor | 1 |
| 22465635 | 10.1016/j.bmcl.2012.03.035 | Rho-associated protein kinase 1 | 1 |
| - | 10.6019/EOS300108 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine